Table 2.
Virus | Primary co-infected | Contact group 1 | Contact group 2 | |||
---|---|---|---|---|---|---|
BALF | Nasal swab | BALF | Nasal swab | BALF | Nasal swab | |
cH1N1 | 0 (0/71) | 0 (0/40) | 0 (0/40) | 0 (0/40) | 0 (0/40) | 0 (0/40) |
rH1N1* | 54.9 (39/71) | 0 (0/40) | 0 (0/40) | 0 (0/40) | 0 (0/40) | 0 (0/40) |
H1N2 | 14.1 (10/71) | 0 (0/40) | 0 (0/40) | 0 (0/40) | 0 (0/40) | 0 (0/40) |
H3N1 | 15.5 (11/71) | 0 (0/40) | 0 (0/40) | 0 (0/40) | 0 (0/40) | 0 (0/40) |
H3N2 | 14.1 (10/71) | 100 (40/40) | 100 (40/40) | 100 (40/40) | 100 (40/40) | 100 (40/40) |
nH3N2† | 1.4 (1/71) | 0 (0/40) | 0 (0/40) | 0 (0/40) | 0 (0/40) | 0 (0/40) |
*Reassortant H1N1.
†Novel H3N2.